Rheumatoid Arthritis in Romania: A Study of Patients and Treatment
Author Information
Author(s): Corina Mogosan, V. Stoica, C. Mihai, L. Macovei, I. Ancuta, C. Ciofu, F. Stefanescu, M. Bojinca, A. Martin, M. Milicescu, V. Crisan, M. Banciu, S. Suteanu
Primary Institution: Carol Davila University of Medicine and Pharmacy Bucharest
Hypothesis
What are the clinical characteristics and healthcare resource utilization of rheumatoid arthritis patients in Romania?
Conclusion
The social influence significantly impacts treatment choices and economic outcomes for rheumatoid arthritis patients in Romania.
Supporting Evidence
- 22.9% of patients were retired within the first year after RA diagnosis.
- Patients treated with biologic DMARDs had a higher average disease duration.
- High levels of pain and disability were reported among participants.
Takeaway
This study looked at how rheumatoid arthritis affects people in Romania and how they are treated. It found that many patients struggle with work and need help.
Methodology
The study used a cross-sectional cohort design with self-reported interviews over 12 months.
Potential Biases
Potential bias due to self-reporting and lack of random sampling.
Limitations
The study lacks a National RA Register and relies on self-reported data.
Participant Demographics
The average age of participants was 54.90 years, with a majority being women and having low education levels.
Statistical Information
P-Value
0.007
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website